Skip to main content

Table 1 Baseline demographic and clinical data

From: Effectiveness and safety of SOF/VEL containing rescue therapy in treating chronic HCV-GT4 patients previously failed NS5A inhibitors-based DAAs

Variable

All cohort

SOF/VEL + RBV

n = 75

SOF/VEL/VOX

n = 75

P value

Mean age (year)

52.8 ± 12.55

23–82

55.07 ± 11.97

50.53 ± 12.79

0.03

Male gender (%)

96(64)

41 (54.67)

55 (73.33)

0.02

Urban residency

96 (64)

36 (48)

60 (80)

< 0.001

Treatment experienced

   

NA

 - SOF/DCV

- 75 (50)

- 0

- 75 (100)

 - SOF/DCV/RBV

- 75 (50)

- 75 (100)

- 0

Smoking

44 (29.33)

8 (10.67)

36 (48)

< 0.001

History of hypertension

20 (13.33)

9 (12)

11 (14.67)

0.63

History of DM

35 (23.33)

16 (21.33)

19 (25.33)

0.56

Con-meds

9

0

9 (100)

NA